Medtech venture investment activity is holding better than biopharma

https://www.jpmorgan.com/content/dam/jpm/commercial-banking/insights/life-sciences/jpmorgan-chase-q2-2022-biopharma-medtech-midyear-outlook-final-ada-report.pdf